Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Reiser Anne
   2. Issuer Name and Ticker or Trading Symbol
RESMED INC [RMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President - ResMed Europe
(Last)
(First)
(Middle)
RESMED INC., 9001 SPECTRUM CENTER BLVD.		 3. Date of Earliest Transaction (Month/Day/Year)
11/21/2012
(Street)

SAN DIEGO, CA 92123		 4. If Amendment, Date Original Filed(Month/Day/Year)
11/23/2012		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
ResMed Common Stock 11/21/2012   M   10,286 (1) A $ 40.72 30,863.705 D  
ResMed Common Stock 11/21/2012   M   5,429 (2) A $ 40.72 36,292.705 D  
ResMed Common Stock 12/31/2012   J   237 (3) D $ 40.72 36,055.705 D  
ResMed Common Stock 12/31/2012   J   125 (4) D $ 40.72 36,803.142 (5) D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Reiser Anne
RESMED INC.
9001 SPECTRUM CENTER BLVD.
SAN DIEGO, CA 92123		       President - ResMed Europe  

Signatures

 Anne Reiser, President-Europe   02/27/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents acceleration of RSUs granted on 12/17/2009 to correct a clerical error and qualify for preferential tax treatment.
(2) Represents acceleration of RSUs granted on 11/11/2010 to correct a clerical error and qualify for preferential tax treatment.
(3) Represents a cancellation of the 11/21/2012 vesting in order to apply correct tax rate which resulted in disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on December 17, 2009.
(4) Represents a cancellation of the 11/21/2012 vesting in order to apply correct tax rate which resulted in disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on November 10, 2010.
(5) Includes 765.796 shares of stock purchased on 4/30/2012 pursuant to ResMed's Employee Purchase Plan. Also includes 106.637 shares purchased on October 31, 2012, through ResMed's Employee Stock Purchase Plan.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.